ArticleInvestigative ophthalmology & visual science2026
Ocular IL-1α/IFN-γ Delay the Corneal Wound Healing in Rheumatoid Arthritis Through Mitochondrial Dysfunction and NLRP3 Inflammasome Activation.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Rheumatoid arthritis (RA) is an autoimmune disease often associated with corneal ulceration and impaired corneal epithelial wound healing (CEWH), although the underlying cause remains unclear. This study aims to elucidate the pathogenic mechanism of RA-associated delayed CEWH. Methods: We integrated analyses of human clinical samples, a murine collagen-induced arthritis (CIA) model, a human corneal epithelial cell (HCEC) culture platform, as well as Olink proteomic and transcriptomic analysis. We characterized RA-related ocular phenotypes, evaluated the effects of IL-1α/IFN-γ on HCECs, and validated interventions using the NLRP3 inflammasome inhibitor MCC950. Results: RA patients exhibited delayed CEWH, reduced tear secretion, and heightened ocular surface inflammation characterized by elevated Oncostatin M (OSM), IL-1α and IFN-γ. OSM alone promoted the proliferation and migration of HCECs and enhanced mitochondrial respiratory capacity. However, these beneficial effects were markedly impaired when OSM-treated HCECs were co-exposed to IL-1α and IFN-γ, an effect accompanied by severe mitochondrial damage, compromised oxidative phosphorylation, and increased NLRP3 inflammasome activity. Notably, pharmacological blockade of NLRP3 inflammasome with MCC950 significantly restored HCEC functions compromised by IL-1α/IFN-γ exposure, with improved mitochondrial ultrastructure and function. Furthermore, topical MCC950 administration accelerated CEWH in the CIA model. Conclusions: Ocular IL-1α/IFN-γ impairs corneal epithelial function by disrupting mitochondrial integrity and amplifying NLRP3-mediated inflammatory cascades, thereby contributing to delayed CEWH in RA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.